BACKGROUND: Prediction of subsequent school-age asthma during the preschool years has proven challenging. OBJECTIVE: To confirm in a post hoc analysis the predictive ability of the modified Asthma Predictive Index (mAPI) ina high-risk cohort and a theoretical unselected population. We also tested a potential mAPI modification with a 2-wheezing episode requirement (m2API) in the same populations. METHODS: Subjects (n [ 289) with a family history of allergy and/or asthma were used to predict asthma at age 6, 8, and 11 years with the use of characteristics collected during the first 3 years of life. The mAPI and the m2API were tested for predictive value. RESULTS: For the mAPI and m2API, school-age asthma prediction improved from 1 to 3 years of age. The mAPI had high predictive value after a positive test (positive likelihood ratio ranging from 4.9 to 55) for asthma development at years 6,8, and 11. Lowering the number of wheezing episodes to 2(m2API) lowered the predictive value after a positive test(positive likelihood ratio ranging from 1.91 to 13.1) without meaningfully improving the predictive value of a negative test.Posttest probabilities for a positive mAPI reached 72% and 90%in unselected and high-risk populations, respectively. CONCLUSIONS: In a high-risk cohort, a positive mAPI greatly increased future asthma probability (eg, 30% pretest probability to 90% posttest probability) and is a preferred predictive test to them 2API. With its more favorable positive posttest probability,the mAPI can aid clinical decision making in assessing future asthma risk for preschool-age children.
BACKGROUND: Prediction of subsequent school-age asthma during the preschool years has proven challenging. OBJECTIVE: To confirm in a post hoc analysis the predictive ability of the modified Asthma Predictive Index (mAPI) ina high-risk cohort and a theoretical unselected population. We also tested a potential mAPI modification with a 2-wheezing episode requirement (m2API) in the same populations. METHODS: Subjects (n [ 289) with a family history of allergy and/or asthma were used to predict asthma at age 6, 8, and 11 years with the use of characteristics collected during the first 3 years of life. The mAPI and the m2API were tested for predictive value. RESULTS: For the mAPI and m2API, school-age asthma prediction improved from 1 to 3 years of age. The mAPI had high predictive value after a positive test (positive likelihood ratio ranging from 4.9 to 55) for asthma development at years 6,8, and 11. Lowering the number of wheezing episodes to 2(m2API) lowered the predictive value after a positive test(positive likelihood ratio ranging from 1.91 to 13.1) without meaningfully improving the predictive value of a negative test.Posttest probabilities for a positive mAPI reached 72% and 90%in unselected and high-risk populations, respectively. CONCLUSIONS: In a high-risk cohort, a positive mAPI greatly increased future asthma probability (eg, 30% pretest probability to 90% posttest probability) and is a preferred predictive test to them 2API. With its more favorable positive posttest probability,the mAPI can aid clinical decision making in assessing future asthma risk for preschool-age children.
Authors: Theresa W Guilbert; Wayne J Morgan; Marzena Krawiec; Robert F Lemanske; Chris Sorkness; Stanley J Szefler; Gary Larsen; Joseph D Spahn; Robert S Zeiger; Gregory Heldt; Robert C Strunk; Leonard B Bacharier; Gordon R Bloomberg; Vernon M Chinchilli; Susan J Boehmer; Elizabeth A Mauger; David T Mauger; Lynn M Taussig; Fernando D Martinez Journal: Control Clin Trials Date: 2004-06
Authors: Daan Caudri; Alet Wijga; C Maarten A Schipper; Maarten Hoekstra; Dirkje S Postma; Gerard H Koppelman; Bert Brunekreef; Henriette A Smit; Johan C de Jongste Journal: J Allergy Clin Immunol Date: 2009-08-08 Impact factor: 10.793
Authors: Theresa W Guilbert; Wayne J Morgan; Robert S Zeiger; David T Mauger; Susan J Boehmer; Stanley J Szefler; Leonard B Bacharier; Robert F Lemanske; Robert C Strunk; David B Allen; Gordon R Bloomberg; Gregory Heldt; Marzena Krawiec; Gary Larsen; Andrew H Liu; Vernon M Chinchilli; Christine A Sorkness; Lynn M Taussig; Fernando D Martinez Journal: N Engl J Med Date: 2006-05-11 Impact factor: 91.245
Authors: Daniel J Jackson; Ronald E Gangnon; Michael D Evans; Kathy A Roberg; Elizabeth L Anderson; Tressa E Pappas; Magnolia C Printz; Wai-Ming Lee; Peter A Shult; Erik Reisdorf; Kirsten T Carlson-Dakes; Lisa P Salazar; Douglas F DaSilva; Christopher J Tisler; James E Gern; Robert F Lemanske Journal: Am J Respir Crit Care Med Date: 2008-06-19 Impact factor: 21.405
Authors: P L P Brand; E Baraldi; H Bisgaard; A L Boner; J A Castro-Rodriguez; A Custovic; J de Blic; J C de Jongste; E Eber; M L Everard; U Frey; M Gappa; L Garcia-Marcos; J Grigg; W Lenney; P Le Souëf; S McKenzie; P J F M Merkus; F Midulla; J Y Paton; G Piacentini; P Pohunek; G A Rossi; P Seddon; M Silverman; P D Sly; S Stick; A Valiulis; W M C van Aalderen; J H Wildhaber; G Wennergren; N Wilson; Z Zivkovic; A Bush Journal: Eur Respir J Date: 2008-10 Impact factor: 16.671
Authors: Sejal Saglani; Donald N Payne; Jie Zhu; Zhuo Wang; Andrew G Nicholson; Andrew Bush; Peter K Jeffery Journal: Am J Respir Crit Care Med Date: 2007-08-16 Impact factor: 21.405
Authors: C S Devulapalli; K C L Carlsen; G Håland; M C Munthe-Kaas; M Pettersen; P Mowinckel; K-H Carlsen Journal: Thorax Date: 2007-07-05 Impact factor: 9.139
Authors: Daniel J Jackson; Christine M Virnig; Ronald E Gangnon; Michael D Evans; Kathy A Roberg; Elizabeth L Anderson; Ryan M Burton; Lisa P Salazar; Douglas F DaSilva; Kathleen M Shanovich; Christopher J Tisler; James E Gern; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2009-09-12 Impact factor: 10.793
Authors: C-I Wi; E A Krusemark; G Voge; S Sohn; H Liu; E Ryu; M A Park; J A Castro-Rodriguez; Y J Juhn Journal: Allergy Date: 2018-02-07 Impact factor: 13.146
Authors: Mohamed S Al-Moamary; Sami A Alhaider; Abdullah A Alangari; Mohammed O Al Ghobain; Mohammed O Zeitouni; Majdy M Idrees; Abdullah F Alanazi; Adel S Al-Harbi; Abdullah A Yousef; Hassan S Alorainy; Mohamed S Al-Hajjaj Journal: Ann Thorac Med Date: 2019 Jan-Mar Impact factor: 2.219
Authors: Elisabet Johansson; Jocelyn M Biagini Myers; Lisa J Martin; Hua He; Patrick Ryan; Grace K LeMasters; David I Bernstein; James Lockey; Gurjit K Khurana Hershey Journal: Clin Exp Allergy Date: 2019-03-27 Impact factor: 5.018
Authors: Michael G Sherenian; Jocelyn M Biagini Myers; Lisa J Martin; Gurjit K Khurana Hershey Journal: Expert Rev Clin Immunol Date: 2019-10-24 Impact factor: 4.473
Authors: Jocelyn M Biagini Myers; Eric Schauberger; Hua He; Lisa J Martin; John Kroner; Gregory M Hill; Patrick H Ryan; Grace K LeMasters; David I Bernstein; James E Lockey; S Hasan Arshad; Ramesh Kurukulaaratchy; Gurjit K Khurana Hershey Journal: J Allergy Clin Immunol Date: 2018-12-13 Impact factor: 10.793
Authors: Sima K Ramratnam; Cynthia M Visness; Katy F Jaffee; Gordon R Bloomberg; Meyer Kattan; Megan T Sandel; Robert A Wood; James E Gern; Rosalind J Wright Journal: Am J Respir Crit Care Med Date: 2017-03-01 Impact factor: 21.405